Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 23.94%, which has investors questioning if this is right time to sell.

The following recap contains spoilers from the April 3 episode of CBS’ Matlock. With four episodes left to air (over the next ...

Aldeyra Therapeutics, Inc.’s ALDX share price has dipped by 76.92%, which has investors questioning if this is right time to ...

Compound Semiconductor™ is an Angel Business Communications publication.

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

Discover growth opportunities with Edgewise Therapeutics, Inc. in the hypertrophic cardiomyopathy market. Click for my EWTX ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating ...

This has led to the development of new technologies such as the electro-optic modulator, acoustic-optic modulator, and ...

Zambian former Olympic sprinter and current USA Track & Field coach Gerald Phiri has been provisionally suspended after three athletes coached by him tested positive for the prohibited substance ...

1 Department of Biochemistry, University of Colorado Boulder, Boulder, CO, United States 2 Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, CO, United States Recent research ...